title: Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
abstract: Exact mechanisms underlying the initiation and progression of estrogen-related cancers are not clear. Literature, evidence and our studies strongly support the role of estrogen metabolism-mediated oxidative stress in estrogen-induced breast carcinogenesis. We have recently demonstrated that antioxidants vitamin C and butylated hydroxyanisole (BHA) or estrogen metabolism inhibitor α-naphthoflavone (ANF) inhibit 17β-estradiol (E2)-induced mammary tumorigenesis in female ACI rats. The objective of the current study was to identify the mechanism of antioxidant-mediated protection against E2-induced DNA damage and mammary tumorigenesis. Female ACI rats were treated with E2 in the presence or absence of vitamin C or BHA or ANF for up to 240 days. Nuclear factor erythroid 2-related factor 2 (NRF2) and NAD(P)H-quinone oxidoreductase 1 (NQO1) were suppressed in E2-exposed mammary tissue and in mammary tumors after treatment of rats with E2 for 240 days. This suppression was overcome by co-treatment of rats with E2 and vitamin C or BHA. Time course studies indicate that NQO1 levels tend to increase after 4 months of E2 treatment but decrease on chronic exposure to E2 for 8 months. Vitamin C and BHA significantly increased NQO1 levels after 120 days. 8-Hydroxydeoxyguanosine (8-OHdG) levels were higher in E2-exposed mammary tissue and in mammary tumors compared with age-matched controls. Vitamin C or BHA treatment significantly decreased E2-mediated increase in 8-OHdG levels in the mammary tissue. In vitro studies using silencer RNA confirmed the role of NQO1 in prevention of oxidative DNA damage. Our studies further demonstrate that NQO1 upregulation by antioxidants is mediated through NRF2.
authors.affiliation: Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
authors.forename: Bhupendra
authors.initials: B
authors.lastname: Singh
authors.forename: Nimee K
authors.initials: NK
authors.lastname: Bhat
authors.forename: Hari K
authors.initials: HK
authors.lastname: Bhat
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology; D001571:Benzoflavones / Q000494:pharmacology; D002083:Butylated Hydroxyanisole / Q000494:pharmacology; D004249:DNA Damage; D004958:Estradiol / Q000633:toxicity*; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000517:prevention & control*; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000096:biosynthesis* / Q000235:genetics; D051267:NF-E2-Related Factor 2 / Q000502:physiology; D009928:Organ Specificity; D010084:Oxidation-Reduction; D051381:Rats; D011912:Rats, Inbred ACI
chemical_list: D000975:Antioxidants; D001571:Benzoflavones; D051267:NF-E2-Related Factor 2; C495637:Nfe2l2 protein, rat; D002083:Butylated Hydroxyanisole; D004958:Estradiol; C011512:alpha-naphthoflavone; D016660:NAD(P)H Dehydrogenase (Quinone); C507703:NQO1 protein, rat; D001205:Ascorbic Acid
references.citation: Toxicol Appl Pharmacol. 2008 Oct 1;232(1):78-85
references.pmid: 18640140
references.citation: Annu Rev Pharmacol Toxicol. 2007;47:89-116
references.pmid: 16968214
references.citation: J Steroid Biochem Mol Biol. 2008 May;110(1-2):157-62
references.pmid: 18456490
references.citation: JAMA. 2002 Jun 26;287(24):3223-9
references.pmid: 12076218
references.citation: Carcinogenesis. 1994 May;15(5):997-1000
references.pmid: 8200107
references.citation: Chem Biol Interact. 2000 Dec 1;129(1-2):77-97
references.pmid: 11154736
references.citation: IARC Sci Publ. 1993;(124):149-55
references.pmid: 8225478
references.citation: Breast Cancer (Auckl). 2009 Jan 06;3:1-8
references.pmid: 21556245
references.citation: Food Chem Toxicol. 1999 Sep-Oct;37(9-10):993-7
references.pmid: 10541456
references.citation: Methods Mol Biol. 1996;59:49-56
references.pmid: 8798186
references.citation: Stroke. 2002 Jun;33(6):1568-73
references.pmid: 12052992
references.citation: Free Radic Biol Med. 2007 Nov 1;43(9):1289-98
references.pmid: 17893042
references.citation: Int J Cancer. 2008 May 1;122(9):1949-57
references.pmid: 18098283
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42
references.pmid: 9380738
references.citation: J Biol Chem. 2000 Dec 22;275(51):40134-41
references.pmid: 11013233
references.citation: Free Radic Biol Med. 2008 Jul 15;45(2):136-45
references.pmid: 18423413
references.citation: Carcinogenesis. 2010 Jan;31(1):90-9
references.pmid: 19793802
references.citation: Methods Enzymol. 2004;382:414-23
references.pmid: 15047114
references.citation: Mutat Res. 2003 Feb-Mar;523-524:173-82
references.pmid: 12628515
references.citation: Free Radic Biol Med. 1990;8(4):415-23
references.pmid: 2199344
references.citation: J Biochem Mol Toxicol. 2009 May-Jun;23(3):202-11
references.pmid: 19526586
references.citation: Oncogene. 2007 May 24;26(24):3587-90
references.pmid: 17160017
references.citation: Carcinogenesis. 2000 Mar;21(3):427-33
references.pmid: 10688862
references.citation: Future Oncol. 2010 Jan;6(1):75-91
references.pmid: 20021210
references.citation: Proc Natl Acad Sci U S A. 1980 Sep;77(9):5216-20
references.pmid: 6933553
references.citation: N Engl J Med. 2001 Jan 25;344(4):276-85
references.pmid: 11172156
references.citation: Free Radic Biol Med. 2001 Dec 1;31(11):1341-51
references.pmid: 11728805
references.citation: Lancet. 2001 Mar 3;357(9257):657-63
references.pmid: 11247548
references.citation: Nature. 1998 Apr 9;392(6676):559
references.pmid: 9560150
references.citation: Lancet. 1999 Dec 11;354(9195):2048-9
references.pmid: 10636373
references.citation: Oncogene. 2011 Mar 3;30(9):1098-107
references.pmid: 21042282
references.citation: Cancer Res. 2010 Feb 1;70(3):1006-14
references.pmid: 20103645
references.citation: J Steroid Biochem Mol Biol. 2004 Dec;92(5):391-8
references.pmid: 15698544
references.citation: Toxicology. 2004 Aug 5;200(2-3):103-11
references.pmid: 15212807
references.citation: Chem Res Toxicol. 2006 Jan;19(1):164-72
references.pmid: 16411670
references.citation: Mol Carcinog. 2002 Jan;33(1):56-65
references.pmid: 11807958
references.citation: J Natl Cancer Inst Monogr. 2000;(27):67-73
references.pmid: 10963620
references.citation: Cancer Res. 1984 Jul;44(7):2858-63
references.pmid: 6426789
references.citation: J Biochem Mol Toxicol. 2004;18(1):37-42
references.pmid: 14994278
references.citation: Cancer Prev Res (Phila). 2008 Jul;1(2):135-45
references.pmid: 19138946
references.citation: Physiol Genomics. 2007 Dec 19;32(1):74-81
references.pmid: 17895394
references.citation: Science. 2001 Jun 15;292(5524):2083-6
references.pmid: 11408659
references.citation: Mol Endocrinol. 2003 Jul;17(7):1344-55
references.pmid: 12714703
references.citation: J Steroid Biochem. 1986 Jan;24(1):353-6
references.pmid: 3009986
references.citation: N Engl J Med. 2006 Jan 19;354(3):270-82
references.pmid: 16421368
references.citation: J Biol Chem. 2003 Mar 7;278(10):8135-45
references.pmid: 12506115
references.citation: Fed Proc. 1987 Apr;46(5):1858-63
references.pmid: 3030825
references.citation: J Biol Chem. 2010 Jan 1;285(1):153-62
references.pmid: 19897490
references.citation: Cancer Res. 1982 Jul;42(7):2609-15
references.pmid: 6805943
references.citation: J Natl Cancer Inst Monogr. 2000;(27):95-112
references.pmid: 10963622
references.citation: Carcinogenesis. 2009 Jul;30(7):1202-8
references.pmid: 19406931
references.citation: Cancer Res. 2000 Jan 15;60(2):235-7
references.pmid: 10667565
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2779-84
references.pmid: 10688907
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3913-8
references.pmid: 12655060